ARCH Venture Fund VII, L.P. - Net Worth and Insider Trading
ARCH Venture Fund VII, L.P. Net Worth
The estimated net worth of ARCH Venture Fund VII, L.P. is at least $165 Million dollars as of 2024-09-27. ARCH Venture Fund VII, L.P. is the 2101 Beneficial owner of Hua Medicine and owns about 125,088,960 shares of Hua Medicine (HKSE:02552) stock worth over $165 Million. Details can be seen in ARCH Venture Fund VII, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that ARCH Venture Fund VII, L.P. has not made any transactions after 2018-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of ARCH Venture Fund VII, L.P.
ARCH Venture Fund VII, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, ARCH Venture Fund VII, L.P. owns 1 companies in total, including Hua Medicine (HKSE:02552) .
Click here to see the complete history of ARCH Venture Fund VII, L.P.’s form 4 insider trades.
Insider Ownership Summary of ARCH Venture Fund VII, L.P.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02552 | Hua Medicine | 2018-09-14 | 2101 Beneficial owner |
ARCH Venture Fund VII, L.P. Latest Holdings Summary
ARCH Venture Fund VII, L.P. currently owns a total of 1 stock. ARCH Venture Fund VII, L.P. owns 125,088,960 shares of Hua Medicine (HKSE:02552) as of September 14, 2018, with a value of $165 Million.
Latest Holdings of ARCH Venture Fund VII, L.P.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02552 | Hua Medicine | 2018-09-14 | 125,088,960 | 1.32 | 165,117,427 |
Holding Weightings of ARCH Venture Fund VII, L.P.
ARCH Venture Fund VII, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, ARCH Venture Fund VII, L.P. has made a total of 0 transactions in Hua Medicine (HKSE:02552) over the past 5 years. The most-recent trade in Hua Medicine is the sale of 0 shares on September 14, 2018, which brought ARCH Venture Fund VII, L.P. around $0.
Insider Trading History of ARCH Venture Fund VII, L.P.
- 1
ARCH Venture Fund VII, L.P. Trading Performance
ARCH Venture Fund VII, L.P. Ownership Network
ARCH Venture Fund VII, L.P. Owned Company Details
What does Hua Medicine do?
Who are the key executives at Hua Medicine?
ARCH Venture Fund VII, L.P. is the 2101 Beneficial owner of Hua Medicine. Other key executives at Hua Medicine include 2306 Nominee for another person Hlyy Limited , 2501 Other Tct (bvi) Limited , and 2301 Trustee The Core Trust Company Limited .
Hua Medicine (HKSE:02552) Insider Trades Summary
Over the past 18 months, ARCH Venture Fund VII, L.P. made no insider transaction in Hua Medicine (HKSE:02552). Other recent insider transactions involving Hua Medicine (HKSE:02552) include a net sale of 0 shares made by The Core Trust Company Limited , a net sale of 0 shares made by Tct (bvi) Limited , and a net sale of 0 shares made by Hong Jane Xingfang .
In summary, during the past 3 months, insiders sold 0 shares of Hua Medicine (HKSE:02552) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hua Medicine (HKSE:02552) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Hua Medicine (HKSE:02552)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hua Medicine Insider Transactions
ARCH Venture Fund VII, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for ARCH Venture Fund VII, L.P.. Currently GuruFocus does not have mailing address information for ARCH Venture Fund VII, L.P..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
